Latest Breaking News On - Tarsus pharmaceuticals - Page 22 : comparemela.com

Guggenheim Increases Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $49 00

Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) had its price objective hoisted by equities researchers at Guggenheim from $46.00 to $49.00 in a report released on Monday, MarketBeat Ratings reports. The firm currently has a “buy” rating on the stock. Guggenheim’s target price indicates a potential upside of 198.23% from the stock’s previous close. Several […]

United statesWilliam blairBobakr azamianBlackrock incSecurities exchange commissionTarsus pharmaceuticalsTarsus pharmaceuticals company profileTarsus pharmaceuticals incNews ratings for tarsus pharmaceuticals dailyVanguard group incTarsus pharmaceuticals stock downInstitutional investors weigh in on tarsus pharmaceuticalsJefferies financial group incGet free reportMarketbeat ratingsPharmaceuticals stock down

Contrasting Rubius Therapeutics (NASDAQ:RUBY) and Tarsus Pharmaceuticals (NASDAQ:TARS)

Contrasting Rubius Therapeutics (NASDAQ:RUBY) and Tarsus Pharmaceuticals (NASDAQ:TARS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesTarsus pharmaceuticalsRubius therapeutics incTarsus pharmaceuticals incRubius therapeuticsGet free reportTarsus pharmaceuticalGiven tarsus pharmaceuticalRubius therapeutics daily

OC50 2023: Bill Link - Orange County Business Journal

Announcing Bill Link as part of the 2023 OC50 – the 50 individuals shaping the future of healthcare in OC

Inari medical incAliso viejo rxsight incEdwards lifesciences corpTarsus pharmaceuticals incNewport beach basedFlyingl partnersSan francisco based versantTarsus pharmaceuticalsInari medicalEdwards lifesciencesAliso viejo

Tarsus to Present at Upcoming Investor Conferences

Tarsus to Present at Upcoming Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkBobak azamianAdrienne kempJeff farrowDavid nakasoneMorgan stanleyCorporate communicationsTarsus pharmaceuticals incChief executive officerChief financialStrategy officerNew york cityAnnual global investment conferenceFireside chatAnnual global healthcare conference

Head-To-Head Contrast: Genetic Technologies (NASDAQ:GENE) & Tarsus Pharmaceuticals (NASDAQ:TARS)

Head-To-Head Contrast: Genetic Technologies (NASDAQ:GENE) & Tarsus Pharmaceuticals (NASDAQ:TARS)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesAsia pacificMemorial sloan kettering new york cambridge universityUniversity of melbourneTarsus pharmaceuticals incTarsus pharmaceuticalsOhio state universityTranslational genomics research instituteGenetic technologiesGet free reportGiven tarsus pharmaceuticalTarsus pharmaceuticalTechnologies limitedMiddle eastLatin americaColorectal cancer